about
Middle East respiratory syndrome (MERS): a new zoonotic viral pneumoniaCorynebacterium minutissimum vascular graft infection: case report and review of 281 cases of prosthetic device-related Corynebacterium infection.Implementing an antimicrobial stewardship program in out-patient dialysis units.Antibiotic Prescribing for Urinary Tract Infections in the Emergency Department Based on Local Antibiotic Resistance Patterns: Implications for Antimicrobial Stewardship.Prolonged and perplexing fevers in antiquity: malaria and typhoid fever.Relation of Diagnostic Accuracy of Viral Respiratory Polymerase Chain Reaction to Specimen Number and Source in Severe Adenovirus Pneumonia: Antimicrobial Stewardship Implications.Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.Multiple recurrent abscesses in a patient with undiagnosed IL-12 deficiency and infection by Burkholderia gladioli.Reply to Burnham, Kakol, Vazquez-GuillametAntimicrobial Stewardship Programs: Principles and PracticeAntibiotic Stewardship: Strategies to Minimize Antibiotic Resistance While Maximizing Antibiotic EffectivenessThe Pharmacoeconomic Aspects of Antibiotic Stewardship ProgramsAntibiotic Stewardship Program Perspective: Oral Antibiotic Therapy for Common Infectious DiseasesAn Overview of Antimicrobial Stewardship Programs: Imperatives, Interventions, and InnovationsOpportunities Revealed for Antimicrobial Stewardship and Clinical Practice with Implementation of a Rapid Respiratory Multiplex AssayAntimicrobial Stewardship Programs (ASP): Perspective on Problems and PotentialAntimicrobial Stewardship Program Perspective: IV-to-PO Switch TherapyAntimicrobial Stewardship
P50
Q26991666-4797EA5F-933E-4955-BAB8-416AB77C7D39Q38220712-D9758903-AFB6-4BBD-A1FF-07BD33653D5DQ38956393-B4BC41D9-599D-40E0-A2DE-CFEBFC75FD6AQ40274846-DC217B3A-D5C4-474F-BC6B-E8605DDE1755Q40432792-43E3DE78-7C58-4FC4-BFE7-06E39C6EB988Q40600308-246F63EE-9359-4BC5-B065-309F605C6F8EQ40885142-4B265F66-8A6A-4C7E-B701-61B22A6F12DCQ55322131-02D7DAEE-EC4B-4968-8860-F91FBC880E14Q57283263-03064035-2C9E-4115-970B-817337B3A2EDQ91045132-8A3540B5-D271-43AE-9D8C-0485BA3BF1DEQ91045142-F957874E-30B9-438E-BCF2-09005D716203Q91045279-6440285A-7A61-4C17-AF02-14BA24C6E3BEQ91045281-0B903E5C-DC86-427B-A857-49328DD81E48Q91045292-25E1677B-C716-4740-A7FF-38C16019107FQ92622910-D9E066B9-EB68-4C72-AE3A-ED1E9B572DD3Q95572298-A9AF4F81-35FD-4D42-AE9E-2652CB355E69Q95572301-99A71FEC-8AEC-4B9C-A476-9493C73EAA51Q95693752-0D052919-8840-4AE5-89A4-00CC90F67D03
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Cheston B Cunha
@en
Cheston B Cunha
@nl
type
label
Cheston B Cunha
@en
Cheston B Cunha
@nl
prefLabel
Cheston B Cunha
@en
Cheston B Cunha
@nl
P31
P496
0000-0003-4149-9146